Synapse - Works

Results (5612)

Safety and efficacy of atezolizumab in combination with rituximab plus CHOP in previously untreated patients with diffuse large B-cell lymphoma (DLBCL): Updated analysis of a phase I/II study

Meeting Abstract

Younes, A.; Burke, J. M.; Cheson, B. D.; Diefenbach, C.; Ferrari, S.; Hahn, U. H.; Hawkes, E. A.; Khan, C.; Lossos, I. S.; Musuraca, G.; more...
Blood (2019)

Fulltext@MSK | Save

Increased number of high dose methotrexate cycles and the addition of rituximab is associated with better outcomes in a large primary CNSL cohort

Meeting Abstract

Yerram, P.; Reiss, S. N.; Modelevsky, L.; Schaff, L.; Reiner, A.; Panageas, K.; Grommes, C.
Blood (2019)

Fulltext@MSK | Save

A multi-center dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of fimepinostat (CUDC-907) in combination with venetoclax in patients with relapsed/refractory (R/R) lymphoma

Meeting Abstract

Younes, A.; Batlevi, C. L.; Cohen, J. B.; de Vos, S.; Landsburg, D. J.; Myint, Z. W.; Patel, K.; Phillips, T. J.; Smith, S. M.; Westin, J. R.; more...
Blood (2019)

Fulltext@MSK | Save

Phase 1 dose-finding study investigating CA-4948, an IRAK4 kinase inhibitor, in patients with R/R NHL: Report of initial efficacy and updated safety information

Meeting Abstract

Younes, A.; Nowakowski, G.; Rosenthal, A. C.; Leslie, L. A.; Tun, H. W.; Lunning, M. A.; Isufi, I.; Martell, R.; Patel, K.
Blood (2019)

Fulltext@MSK | Save

Highly favorable outcomes with salvage radiation therapy followed by autologous transplant in relapsed and refractory DLBCL patients with minimal or no response to salvage chemotherapy

Meeting Abstract

Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
Blood (2019)

Fulltext@MSK | Save

Evolution in practice patterns and differences among experts and community healthcare providers in the treatment of patients with chronic lymphocytic leukemia

Meeting Abstract

Xu, B. E.; Rosenthal, K. M.; Marcello, K.; Awan, F. T.; Coutre, S.; Lamanna, N.; Sharman, J. P.; Quill, T. A.; Obholz, K. L.; Zelenetz, A. D.
Blood (2019)

Fulltext@MSK | Save

Final results of prospective treatment with pegylated interferon alfa-2a for patients with polycythemia vera and essential thrombocythemia in first and second-line settings

Meeting Abstract

Yacoub, A.; Mascarenhas, J.; Mesa, R. A.; Kosiorek, H. E.; Rampal, R. K.; Silver, R. T.; Salama, M. E.; Siwoski, O.; Dueck, A. C.; Sandy, L.; more...
Blood (2019)

Fulltext@MSK | Save

Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: A retrospective analysis of real world patients

Meeting Abstract

Yazdy, M. S.; Mato, A. R.; Roeker, L. E.; Jarral, U.; Ujjani, C. S.; Shadman, M.; Skarbnik, A.; Whitaker, K. J.; Deonarine, I.; Kabel, C. C.; more...
Blood (2019)

Fulltext@MSK | Save

Inotuzumab ozogamicin is an effective salvage therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with high-risk molecular features, including TP53 loss

Meeting Abstract

Yang, X.; King, A. C.; Kabel, C. C.; Forlenza, C. J.; Park, J. H.; Geyer, M. B.
Blood (2019)

Fulltext@MSK | Save

Graft versus host disease leads to elimination of tissue-resident innate lymphoid cells following experimental and clinical allogeneic transplantation

Meeting Abstract

Vinci, P.; Garcia-Martinez, E.; O'Connor, M. H.; Egorova, A.; Kuttiyara, J.; Arnhold, V.; Ponce, D. M.; Hanash, A. M.
Blood (2019)

Fulltext@MSK | Save